Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05616130 · ClinicalTrials.gov registry record

Pathological Myeloid Activation After Sepsis and Trauma

A clinical trial of Sepsis and Trauma Injury, sponsored by University of Florida.

Recruiting
Registry status
255
Enrollment target
1
Study location

NCT05616130: Recruiting study of Sepsis and Trauma Injury, sponsored by University of Florida.

NCT05616130 is a study of Sepsis and Trauma Injury that is actively recruiting participants, run by University of Florida. The registered enrollment target is 255 participants, below the 6,562-participant average among 90 other Sepsis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05616130, a study of Sepsis and Trauma Injury, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
255 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to better understand what happens to circulating blood after a patient experiences severe trauma injury. The main questions it aims to answer are: Is severe human trauma associated with specific patterns of development in the hematopoietic stem cells of these patients? and Does the initial severe trauma injury create immunosuppression and increase risk of in-hospital sepsis? Participants in study will give blood samples and a waste sample of bone marrow at time of operative repair of traumatic orthopedic injuries, supply medical information and participate in surveys and assessments during recovery from their injury(ies). Researchers will compare severe trauma injury patients to elective hip repair patients to see if immunosuppression and specific development patterns occur in the trauma patient versus the otherwise healthy hip surgery patient.

Primary Outcome

With subsequent sepsis development, MDSCs induce their continued expansion through exocrine and paracrine signaling to HSPCs. HSPCs and MDSCs derived from severe blunt trauma patients will be analyzed for epigenetic (MAPit DNA methylation) and functional changes (ability to generate colony forming units (CFUs)) that initiate sepsis and continue the expansion of immunosuppressive MDSCs.

Interventions

  • OTHER Data Collection
  • PROCEDURE Bone marrow collection and blood collection
  • OTHER Serial interviews to complete surveys and questionnaires
  • OTHER Telephone follow up call

Study Locations (1)

Florida

  • UF Health at Shands Hospital - Gainesville

Trial Details

FieldValue
Enrollment Target 255 participants
Start Date 2022-09-01
Est. Completion 2028-09-30
University of Florida

1,106 total trials

What NCT05616130 shows while recruiting

NCT05616130 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, below the 6,562-participant average among 90 other Sepsis trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Sepsis appearing as the primary indexed condition, and to 4 interventions - of which Data Collection is the first listed.

NCT05616130 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05616130 about?

NCT05616130 is a clinical study titled "Pathological Myeloid Activation After Sepsis and Trauma". The goal of this observational study is to better understand what happens to circulating blood after a patient experiences severe trauma injury. The main questions it aims to answer are: Is severe human trauma associated with specific patterns of development in the hematopoietic stem cells of these ...

What is the current status of trial NCT05616130?

This trial is currently recruiting. The enrollment target is 255 participants. The study started on 2022-09-01. Estimated completion is 2028-09-30.

What conditions does trial NCT05616130 study?

This clinical trial studies the following conditions: Sepsis, Trauma Injury, Immunosuppression, Chronic Critical Illness.

What interventions are being tested in trial NCT05616130?

The interventions under investigation include: Data Collection (OTHER), Bone marrow collection and blood collection (PROCEDURE), Serial interviews to complete surveys and questionnaires (OTHER), Telephone follow up call (OTHER).

Who is sponsoring clinical trial NCT05616130?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05616130 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sepsis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05616130's enrollment target sits among peer trials

255 38th of 90 higher than 53 of 90 other Sepsis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04623424 · 255 participants

    Intestinal Microbiota in Stem Cell Transplant Transplant Admission

  • NCT05114798 · 255 participants · NA

    Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

  • NCT05336188 · 255 participants · Phase 2

    Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

  • NCT05486637 · 255 participants · Early Phase 1

    Vocal Emotion Communication With Cochlear Implants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05616130, the US trial registry maintained by the National Library of Medicine. NCT05616130 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.